Appointment of Non-Executive Director

Helios Underwriting Plc
30 August 2024
 

Helios Underwriting plc

("Helios" or the "Company")

30 August 2024

Appointment of Non-Executive Director

Helios Underwriting ('Helios' or the 'Company'), the investment vehicle which builds shareholder value through participation at Lloyd's, the world's largest insurance market, is pleased to announce the appointment to the Board of Katharine Wade as an Independent Non-Executive Director, effective immediately.

 

Katharine brings over 29 years of experience in financial markets, at Board and management level roles within the UK and internationally. Katharine currently serves as Chief Financial Officer at Aegis, the top quartile Lloyd's syndicate, where she is responsible for strategy, capital raising and financial controls. Katharine has also held CFO roles at the UK entities within the Aspen Group (Aspen Insurance UK Limited and Aspen Managing Agency Limited) and ACE Tempest Re.

 

Katharine's iNED experience includes being a non-executive director of Atlas Corporation (listed on NYSE) and membership of the Investment Committee of the Council of Lloyd's, where she monitors and oversees the Treasury and Investment department and the performance of the Lloyd's Investment Platform. She is also a fellow of the Institute of Chartered Accountants of England and Wales, Chair of the Worshipful Company of Insurers Charitable trust, and Court Assistant for the Worshipful Company of Insurers.

 

Executive Chairman Michael Wade comments: "I am delighted, on behalf of the Board, to welcome Katie Wade as an Independent Non-Executive Director to Helios Underwriting plc. Katie's considerable experience, strong financial background and charitable service will make a valuable addition to the Company. As we broaden our Board composition our goal is to continue to introduce external experience and independent viewpoints.

 

"The Company continues to benefit from the exceptionally strong pipeline profits already earned during 2022 and 2023 and we are planning our 2025 portfolio, where we aim to attract more third party capital to participate. Overall, our Lloyd's syndicate portfolio looks set to generate attractive returns, given the outstanding performance of the Lloyd's market, which underpins our confidence in the future performance of the business."

 

AIM Rule 17

The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies:

 

Katharine Anne Wade (nee Kelsey), aged 51, holds no shares or interest in Helios. Katharine's current and previous directorships are as follows:

 

Current Partnerships / Directorships

Previous Partnerships / Directorships (last 5 years)

AEGIS Managing Agency Limited

Scorpius Nutrition Limited

The Worshipful Company of Insurers Charitable Trust

Atlas Corporation

Teddington School Trust

 

Save as disclosed above, there are no further disclosures to be made in accordance with Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

For further information, please contact:

Helios Underwriting plc

Michael Wade - Executive Chairman

Arthur Manners - Chief Financial Officer 
+44 (0)203 965 6441    


Deutsche Numis (Nomad and Broker)                                      

 Giles Rolls / Charles Farquhar                                    

+44 (0)20 7260 1000

 

FTI Consulting

 Ed Berry / Nathan Hambrook-Skinner

+44 (0)7703 330 199 / +44 (0)7977 817 092

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £512m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings